Elsevier

The Journal of Pediatrics

Volume 117, Issue 5, November 1990, Pages 827-829
The Journal of Pediatrics

Clinical and laboratory observation
Comparison of mupirocin and erythromycin in the treatment of impetigo*

https://doi.org/10.1016/S0022-3476(05)83352-9Get rights and content

First page preview

First page preview
Click to open first page preview

References (14)

  • SchachnerL et al.

    A therapeutic update of superficial skin infections

    Pediatr Clin North Am

    (1983)
  • BaltimoreRS

    Treatment of impetigo: a review

    Pediatr Infect Dis

    (1985)
  • SutherlandR et al.

    Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use

    Antimicrob Agents Chemother

    (1985)
  • LeydenJJ

    Mupirocin: a new topical antibiotic

    Semin Dermatol

    (1987)
  • OrecchioRM et al.

    A double-blind multiclinic comparative trial of mupirocin and its vehicle in the treatment of bacterial skin infections

    Curr Ther Res

    (1986)
  • EellsLD et al.

    Topical antibiotic treatment of impetigo with mupirocin

    Arch Dermatol

    (1986)
  • DuxPH et al.

    Two percent topical mupirocin versus systemic erythromycin and cloxacillin in primary and secondary skin infections

    Curr Ther Res

    (1986)
There are more references available in the full text version of this article.

Cited by (39)

  • Streptococcus pyogenes

    2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  • Skin and soft tissue infections

    2009, Medicina Clinica
  • BACTERIAL SKIN INFECTIONS

    2009, Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth Edition
  • Impetigo

    2006, Annales de Dermatologie et de Venereologie
  • Soft tissue disease

    2003, Rheumatic Disease Clinics of North America
  • Topical antibacterial agents

    2000, Infectious Disease Clinics of North America
    Citation Excerpt :

    Work has shown that mupirocin is as effective as oral erythromycin for treatment of impetigo and produces fewer side effects.2,27,66 A double-blind, placebo-controlled, randomized study confirmed the comparable efficacy of mupirocin and oral erythromycin for impetigo and showed better compliance (85% vs 65%) with mupirocin.8 Trials comparing mupirocin to anti-staphylococcal penicillins for primary impetigo are needed.

View all citing articles on Scopus
*

Sponsored and supported by the United States Navy Bureau of Medicine and Surgery Clinical Investigation Program, case No. 88-08-2461-00.

The views expressed here are those of the authors and do not reflect the official policy or position of the United States Navy, the Department of Defense, or the United States Government.

View full text